➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKinsey
AstraZeneca
Merck
Colorcon

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Potassium iodide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for potassium iodide and what is the scope of freedom to operate?

Potassium iodide is the generic ingredient in five branded drugs marketed by Mission Pharmacal Co, Roxane, Arco Pharms Llc, Anbex, Meda Pharms, and Recip, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are two hundred and forty drug master file entries for potassium iodide. Two suppliers are listed for this compound.

Drug Prices for potassium iodide

See drug prices for potassium iodide

Recent Clinical Trials for potassium iodide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityPhase 4
Nourhan M.AlyPhase 2/Phase 3
Alexandria UniversityPhase 2/Phase 3

See all potassium iodide clinical trials

US Patents and Regulatory Information for potassium iodide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane POTASSIUM IODIDE potassium iodide SOLUTION;ORAL 018551-001 Feb 19, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Anbex IOSAT potassium iodide TABLET;ORAL 018664-002 May 12, 2011 OTC Yes No   Start Trial   Start Trial   Start Trial
Meda Pharms THYRO-BLOCK potassium iodide TABLET;ORAL 018307-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mission Pharmacal Co POTASSIUM IODIDE potassium iodide SOLUTION;ORAL 206211-001 Mar 24, 2016 OTC No No   Start Trial   Start Trial   Start Trial
Anbex IOSAT potassium iodide TABLET;ORAL 018664-001 Oct 14, 1982 OTC Yes Yes   Start Trial   Start Trial   Start Trial
Recip THYROSAFE potassium iodide TABLET;ORAL 076350-001 Sep 10, 2002 OTC No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Merck
Express Scripts
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.